Genotyping Assay Market projected to reach $37.1 billion by 2029, with key drivers driving growth

From GlobeNewswire: 2024-07-08 08:30:00

The Genotyping Assay Market is projected to reach $37.1 billion by 2029, growing at a CAGR of 13.8%. Advancements in technology, reduced sequencing costs, and increasing genetic disorders are key drivers. Thermo Fisher Scientific, Illumina, and Danaher Corporation are leading players. Reagents & kits dominate the market, with PCR technology and pharmacogenomics leading in 2023.

Thermo Fisher Scientific Inc. leads the Genotyping Assay Market with a diverse product range and global presence. Illumina, Inc. focuses on innovation and partnerships to maintain its position. Danaher Corporation expands through strategic acquisitions, while QIAGEN excels with comprehensive solutions. Eurofins Scientific diversifies offerings for market expansion. F. Hoffmann-La Roche Ltd. leads in innovations and growth strategies.

The Genotyping Assay Market is segmented by product & service, technology, application, and end-user. Reagents & kits dominate the market, PCR leads in technology, and pharmacogenomics is the top application. Biopharmaceutical & pharmaceutical companies are the major end-users. North America is the largest market, with the Asia Pacific showing high growth potential.



Read more at GlobeNewswire: $19.4B to $37.1B Growth Forecast